ChemImage Demonstrates Innovative Mail Screening Product for Use in Correctional Facilities

ChemImage will offer live demonstrations of their newest product, the VeroVision™Mail Screener, at the New Jersey County Jail Wardens Association (NJCJWA) Annual Meeting in Atlantic City, NJ from October 6 - 8, 2015. The product utilizes shortwave infrared imaging technology to detect hidden illicit drug substances. The capabilities of the VeroVision Mail Screener will be displayed to hundreds of participants in attendance at the conference, comprised mainly of Sheriffs, Wardens, Directors, Deputy Wardens, Administrative Staff and Training Officers from New Jersey.

The VeroVision Mail Screener scans articles of mail, and detects illicit drugs and common cutting agents. The system features a simple, one-click user interface that allows the operator to scan mail within seconds and clearly confirm the presence of illicit drug substances. Using shortwave infrared light, the system can reveal what is invisible to the human eye. The system incorporates advanced acquisition and processing methods to detect illicit substances and displays the detections to the mail screener.

About ChemImage Corporation

ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.

ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics. 

For more information, contact ChemImage.